Your session is about to expire
← Back to Search
VCHIPS for Emotional Distress (VCHIPS Trial)
N/A
Waitlist Available
Led By Alexia M Torke, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up communication quality will be measured daily during the first week and twice a week thereafter for the duration of the hospital stay, up to 1 year
Awards & highlights
VCHIPS Trial Summary
This trial is testing whether audio/video conferences can help surrogate decision makers for hospitalized patients with Alzheimer's, delirium, or other cognitive impairments stay up-to-date on the patient's condition.
Eligible Conditions
- Emotional Distress
- Anxiety
- Communication
- Depression
VCHIPS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ communication quality will be measured daily during the first week and twice a week thereafter for the duration of the hospital stay, up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~communication quality will be measured daily during the first week and twice a week thereafter for the duration of the hospital stay, up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Measure change in ratings of communication quality among study participants using the FICS at baseline, 6-8 weeks after patient discharge, and 6 months after patient discharge
Secondary outcome measures
Measure change in anxiety among study participants using the GAD-7 at baseline, 6-8 weeks after discharge, and 6 months after discharge
Measure change in participant depression among study participants using the PHQ-8 at baseline, 6-8 weeks after discharge, and 6 months after discharge
Measure change in participants' ratings of communication quality over time for the duration of the patient's hospital stay
+2 moreOther outcome measures
Measure the change in blood pressure in patients in the intervention group before and after study intervention
Measure the change in heart rate in patients in the intervention group before and after study intervention
Measure the change in observable and/or reported level of distress in patients in the intervention group before and after study intervention
+2 moreVCHIPS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: VCHIPS: Intervention GroupExperimental Treatment1 Intervention
Individuals in this group will work with a study nurse to schedule the intervention.
Group II: Usual Care: Control GroupActive Control1 Intervention
No interventions administered. Participant will receive usual care in the hospital.
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,161 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,005,114 Total Patients Enrolled
1 Trials studying Emotional Distress
20 Patients Enrolled for Emotional Distress
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,579 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The person who will take care of you cannot be with you every day.The person acting as your surrogate is 18 years old or older.You must have someone who can make medical decisions for you if you are unable to do so. This can be someone you have designated on a healthcare representative form or someone allowed by Indiana law.You are 65 years old or older.Your cognitive impairment is so severe that you need someone else to make all medical decisions for you.You must be able to speak English.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care: Control Group
- Group 2: VCHIPS: Intervention Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still patient slots available for this research endeavor?
"Per clinicaltrials.gov, this medical trial is actively searching for test subjects to participate in the experiment. The research was initially posted on April 18th 2022 and had its most recent update on May 26th 2022."
Answered by AI
What is the upper boundary for enrollment in this medical experiment?
"Affirmative. Per the information available on clinicaltrials.gov, this research project remains open to applicants and was initially posted in April 18th 2022 before being amended on May 26th 2022. The trial requires 36 participants from a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger